(MedPage Today) — Another study linked GLP-1 receptor agonist use with higher odds of developing nonarteritic anterior ischemic optic neuropathy, a potentially blinding eye condition. Last month, the European Medicines Agency warned of this possible…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/116719
Author :
Publish date : 2025-07-29 16:49:00
Copyright for syndicated content belongs to the linked Source.
